ARTICLE
22 August 2023

Healthcare & Life Sciences Private Equity Deal Tracker: Coalesce Capital Recapitalizes Examinetics

Coalesce Capital has announced it has participated in a recapitalization of Examinetics.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

Coalesce Capital has announced it has participated in a recapitalization of Examinetics.

Examinetics, founded in 2004 and based in Overland Park, Kan., is a provider of mobile occupational health screening services, tests and data management.

Coalesce, based in New York, is a middle market private equity firm focused on investing in human capital and technology-enabled business services companies. The firm primarily makes control investments in companies with at least$5 million of EBITDAand$25 million of revenue.

Coalesce partnered with Freedom 3 Capital, an existing Examinetics shareholder, and management for the recapitalization.

Terms of the investment were not disclosed.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

ARTICLE
22 August 2023

Healthcare & Life Sciences Private Equity Deal Tracker: Coalesce Capital Recapitalizes Examinetics

United States Food, Drugs, Healthcare, Life Sciences

Contributor

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More